With Praventin,
the median improvement among the subjects
was a 71% reduction in blemishes by week
4 and a 95% reduction by week 8.
Praventin
is a clinically proven bioactive protein,
rich in lactoferrin, which has been shown
to reduce the development of the bacteria
responsible for many skin impurities,
helping to prevent the formation of blemishes
and spots due to its antimicrobial effects.
Below
are the results of consumer research studies
proving the benefits of Praventin on both
Asian & Caucasian skin types when consumed
daily over a period of 4 to 8 weeks.
Subscribe
to our mailing list and be the first to find out
about our latest offers, product launches and
news.
With Praventin, the median
improvement among the subjects was a 44% reduction
in blemishes by week 2, a 71% reduction
by week 4, and a 95% reduction by
week 8.
Consumer
Research Study 1 - Test
Market Group
Consumption of
Praventin for 8 weeks
44 subjects: 200 mg per day
Front Profile Photographs
Independent photographer (Giovanni,
R. Treadwell Photography)
Consumption Journals
Analyze daily consumption patterns
of the young adults taking Praventin, and in
addition to changes in blemishes and redness.
Independent dermatological
acne scoring
(Clark, J., P.A., Oneonta LaserDerm)
Independent bio-statistical
analysis
(Dawson, J., Iowa State University)
Male
subject #13 week 1
Male
subject #13 week 8
Female
subject #10 week 1
Female
subject #10 week 8
Male
subject #43 week 1
Male
subject #43 week 8
Consumer
Research Study 2 - Test
Market Group
3 dosages of Praventin for 8 weeks
12 subjects: 25* mg per day
12 subjects: 100* mg per day
12 subjects: 200* mg per day
Front Profile Photographs
Independent photographer (Giovanni,
R. Treadwell Photography)
Consumption Journals
Analyze daily consumption patterns of
the young adults taking Praventin, and in addition to
changes in blemishes and redness.
Independent dermatological acne scoring
(Clark, J., P.A., Oneonta LaserDerm)
Independent bio-statistical analysis (Dawson,
J., Iowa State University)
100mg
subject #54 week 0 and 8
100mg
subject #26 week 0 and 8
100mg
subject #60 week 0 and 8
100mg
subject #77 week 0 and 8
200mg
subject #11 week 0 and 8
200mg
subject #35 week 0 and 8
200mg
subject #82 week 0 and 8
Clinical
Research Study 1 - Effectiveness
on Ethnic Skin Types
New Delhi, India (Dept. Dermatology,
Venerology & Leprosy, Dr. RML Hospital)
1 dosage study: 200 mg Praventin, twice
daily (no placebo)
14 subjects (4 male and 10 female) with
mild to moderate acne, 15-27 years (av. 21)
Examination and photographs at week
0, 2, 4, 8 and 12 weeks. Interviewed on self assessment
of acne, complexion and self esteem/confidence.
Photographs and data assessed by independent
dermatologist